Journal of Pharmaceutical Care 2017. 5(1-2):37-41.

Chronic Bacterial Prostatitis due to Staphylococcus haemolyticus; Case Report
Sholeh Ebrahimpour, Sirous Jafari

Abstract


Abstract

Prostatitis causes up to 25% of male genitourinary complaint. However, due to technical restrictions in sampling, only in 10% of cases pathogens were identified. In this paper, a patient with chronic prostatitis due to Staphylococcus hemolyticus is described. A 48-year-old man was referred with longstanding (approximately for 18 months) complaint of increased genitourinary symptoms and pain in perineum. In evaluation, moderate growth of methicillin-resistant Staphylococcus hemolyticus (MRSH) in post-prostatic massage voided urine and expressed prostatic secretion (EPS) was positive. Culture of urethral urine (urine or voided bladder 1; VB1), midstream urine (VB2) and post-ejaculation urine specimens were negative. Leukocyte count values in EPS and post-prostatic massage voided urine were 14 and 8 per oil immersion field respectively. PCR of urine samples was positive for Ureaplasma urealyticum and confirmed by repeated analysis.

Based on the antimicrobial susceptibility results patient was treated with teicoplanin 400 mg intramuscularly every 12 hours for three doses followed by the daily maintenance dose of 400 mg.  In addition, doxycycline 100 mg twice daily was added to cover Ureaplasma urealyticum. Treatment course completed in 6 weeks. Alleviation of patient’s symptoms begun within the first week of treatment and this trend continued until the end of the treatment.


Keywords


Prostatitis; Staphylococcus hemolyticus; Teicoplanin

Full Text:

PDF

References


References

Lipsky BA, Byren I, Hoey CT. Treatment of bacterial prostatitis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010;50(12):1641-52.

de la Rosette JJ, Hubregtse MR, Meuleman EJ, Stolk-Engelaar MV, Debruyne FM. Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology. 1993;41(4):301-7.

Zhao WP, Li YT, Chen J, Zhang ZG, Jiang H, Xia D, et al. Prostatic calculi influence the antimicrobial efficacy in men with chronic bacterial prostatitis. Asian journal of andrology. 2012;14(5):715-9.

Yoon BI, Kim S, Han DS, Ha US, Lee SJ, Kim HW, et al. Acute bacterial prostatitis: how to prevent and manage chronic infection? Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2012;18(4):444-50.

Schaeffer AJ. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. The New England journal of medicine. 2006;355(16):1690-8.

Domingue GJ, Sr., Hellstrom WJ. Prostatitis. Clinical microbiology reviews. 1998;11(4):604-13.

Seo Y, Lee G. Antimicrobial Resistance Pattern in Enterococcus faecalis Strains Isolated From Expressed Prostatic Secretions of Patients With Chronic Bacterial Prostatitis. Korean Journal of Urology. 2013;54(7):477-81.

SU Yun-qin LJ-z, LI Ju-xiang, XIE Qing-fang, YIN Geng-sheng. Identification and drug resistance analysis of pathogenic bacteria in 121 patients with chronic bacterial prostatitis. Chin J Pathophysiol. 2012;28(5):941-3.

Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clinical microbiology reviews. 2014;27(4):870-926.

Choi YS, Kim KS, Choi SW, Kim S, Bae WJ, Cho HJ, et al. Microbiological etiology of bacterial prostatitis in general hospital and primary care clinic in Korea. Prostate international. 2013;1(3):133-8.

Choi YS, Kim KS, Choi SW, Kim S, Bae WJ, Cho HJ, et al. Microbiological etiology of bacterial prostatitis in general hospital and primary care clinic in Korea. Prostate international. 2013;1(3):133-8.

Charalabopoulos K, Karachalios G, Baltogiannis D, Charalabopoulos A, Giannakopoulos X, Sofikitis N. Penetration of antimicrobial agents into the prostate. Chemotherapy. 2003;49(6):269-79.

Baker SD, Horger DC, Keane TE. Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess. Urology. 2004;64(4):808-10.

Pierce JR, Jr., Saeed Q, Davis WR. Prostatic abscess due to community-acquired methicillin-resistant Staphylococcus aureus. The American journal of the medical sciences. 2008;335(2):154-6.

Naboush A, Abou Yassine A, Yasmin M, Mobarakai N. Community-Acquired Methicillin-Resistant Staphylococcus aureus Prostatic Abscess Presenting as Acute Urinary Retention: A Case Report and Review of the Literature. Case reports in infectious diseases. 2013;2013:761793.

Gautam M, Gandhi A, Rose F. Methicillin-resistant Staphylococcus aureus: fatal prostatic abscess in an AIDS patient. Southern medical journal. 2008;101(4):449.

Abreu D, Arroyo C, Suarez R, Campolo H, Izaguirre J, Decia R, et al. Community-acquired methicillin resistant Staphylococcus aureus: a new aetiological agent of prostatic abscess. BMJ case reports. 2011;2011.

Park SC, Lee JW, Rim JS. Prostatic abscess caused by community-acquired methicillin-resistant Staphylococcus aureus. International journal of urology : official journal of the Japanese Urological Association. 2011;18(7):536-8.

Flannery MT, Humphrey D. Case report of a prostatic abscess with a review of the literature. Case reports in medicine. 2012;2012:430657.

Wang H, Chen ZH, Zhu YY, Wang T, Wu XJ. [Penetrability and therapeutic effect of vancomycin to the prostates of rats with bacterial prostatitis (BP) or BPH-BP]. Zhonghua nan ke xue = National journal of andrology. 2006;12(6):490-5.

CLSI. M100S, Performance Standards for Antimicrobial Susceptibility Testing,Twenty-sixth informational supplement. 2016.

Karabakan M, Akdemir S, Akdemir AO, Erkmen AE, Kayabas U. A rare case of prostatic brucellosis mimicking prostate cancer. Urology journal. 2014;11(6):1987-8.

Dobrovol'skaia LI, Gorpinchenko, II. [Benemycin (rifampicin) concentration in the sex gland excretions in chronic prostatitis]. Antibiotiki. 1980;25(4):296-9.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.